Clinical significance of serum vascular endothelial growth factor in malignant pleural mesothelioma

Journal of Thoracic Oncology

Volumn 6, Issue 5, 2011, Pages 971-972

  Fujimoto, Nobukazu ^a   Gemba, Kenichi ^a   Kishimoto, Takumi ^a  

^a OKAYAMA ROSAI HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ANGIOGENESIS; BLOOD LEVEL; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; MALIGNANT MESOTHELIOMA; NONHUMAN; OVERALL SURVIVAL; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR VOLUME;

EID: 79955412868     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e318215a384     Document Type: Letter

References (2)

1. Yasumitsu A, Tabata C, Tabata R, et al. Clinical significance of serum vascular endothelial growth factor in malignant pleural mesothelioma. J Thorac Oncol 2010;5:479-483.
2. Demirag F, Unsal E, Yilmaz A, et al. Prognostic significance of vascular endothelial growth factor, tumor necrosis, and mitotic activity index in malignant pleural mesothelioma. Chest 2005;128:3382-3387. (Pubitemid 41698667)